Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)

Seiichi Kobayashi, Naoya Fujino, Satoshi Suzuki, Masaru Yanai

Research output: Contribution to journalArticlepeer-review


Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung cancer for which there is no optimal therapy for non-resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S-1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S-1 is a novel option for the treatment of advanced BAC.

Original languageEnglish
Pages (from-to)771-772
Number of pages2
Issue number5
Publication statusPublished - 2009 Jul


  • Bronchioloalveolar
  • Chemotherapy
  • Lung cancer
  • Refractory


Dive into the research topics of 'Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)'. Together they form a unique fingerprint.

Cite this